Marta Velia Antonini: Can Nitric Oxide Protect the ECMO Circuit Without Systemic Anticoagulation?
Marta Velia Antonini, Hematologist, Perfusionist ECMO and NRP Specialist and Chair of the Normothermic Regional Perfusion EuroELSO Working Group, shared on X:
“sNO in anticoagulation-contraindicated adult ECMO to provide localized antiplatelet activity at blood-circuit interface without intentionally inducing systemic anticoagulation??
10 patients with clinically significant bleeding risk 3 VV, 6 VA, 1 VP; 90% survived to decannulation
NO delivered at 20 ppm via a system connected to ML sweep-gas pathway for 2–72 days; systemic anticoagulation and antiplatelets withheld
no ML replacement for thrombosis, gas-exchange failure, pressure drop elevation, hemolysis
ML ΔP remained below 50 mm Hg in all patients
MAX MetHb 1-3.4%
no patient required sNO discontinuation
sNO was feasible in this series, and not associated with NO-attributable safety events/complications”

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments